Clinical Trial Update: Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection

View source ↗

Summary

This clinical trial evaluates osilodrostat therapy with 11C-methionine PET to improve corticotroph adenoma detection; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease
• Hypercortisolism
• Pituitary Acth-secreting Adenoma
• Pituitary Adenoma

Drugs mentioned

• Isturisa (osilodrostat)

Snippet

Sponsor: Imperial College London | Conditions: Cushing's Disease, Hypercortisolism | Status: NOT_YET_RECRUITING